Christopher J. Calamari - Net Worth and Insider Trading
Christopher J. Calamari Net Worth
The estimated net worth of Christopher J. Calamari is at least $7 Million dollars as of 2024-11-08. Christopher J. Calamari is the SENIOR VICE PRESIDENT of Abbott Laboratories and owns about 55,952 shares of Abbott Laboratories (ABT) stock worth over $7 Million. Details can be seen in Christopher J. Calamari's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher J. Calamari has not made any transactions after 2022-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher J. Calamari
Christopher J. Calamari Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher J. Calamari owns 1 companies in total, including Abbott Laboratories (ABT) .
Click here to see the complete history of Christopher J. Calamari’s form 4 insider trades.
Insider Ownership Summary of Christopher J. Calamari
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABT | Abbott Laboratories | 2022-03-01 | SENIOR VICE PRESIDENT |
Christopher J. Calamari Latest Holdings Summary
Christopher J. Calamari currently owns a total of 1 stock. Christopher J. Calamari owns 55,952 shares of Abbott Laboratories (ABT) as of March 1, 2022, with a value of $7 Million.
Latest Holdings of Christopher J. Calamari
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABT | Abbott Laboratories | 2022-03-01 | 55,952 | 116.59 | 6,523,444 |
Holding Weightings of Christopher J. Calamari
Christopher J. Calamari Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher J. Calamari has made a total of 1 transactions in Abbott Laboratories (ABT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Abbott Laboratories is the sale of 706 shares on March 1, 2022, which brought Christopher J. Calamari around $83,414.
Insider Trading History of Christopher J. Calamari
- 1
Christopher J. Calamari Trading Performance
Christopher J. Calamari Ownership Network
Ownership Network List of Christopher J. Calamari
Ownership Network Relation of Christopher J. Calamari
Christopher J. Calamari Owned Company Details
What does Abbott Laboratories do?
Who are the key executives at Abbott Laboratories?
Christopher J. Calamari is the SENIOR VICE PRESIDENT of Abbott Laboratories. Other key executives at Abbott Laboratories include Executive Vice President Hubert L Allen , Senior Vice President Robert B Ford , and VICE PRESIDENT Mccoy John A. Jr. .
Abbott Laboratories (ABT) Insider Trades Summary
Over the past 18 months, Christopher J. Calamari made no insider transaction in Abbott Laboratories (ABT). Other recent insider transactions involving Abbott Laboratories (ABT) include a net sale of 80,400 shares made by Andrea F Wainer , a net sale of 158,274 shares made by Hubert L Allen , and a net sale of 100,000 shares made by Daniel J Starks .
In summary, during the past 3 months, insiders sold 299,127 shares of Abbott Laboratories (ABT) in total and bought 0 shares, with a net sale of 299,127 shares. During the past 18 months, 524,935 shares of Abbott Laboratories (ABT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 524,935 shares.
Abbott Laboratories (ABT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Abbott Laboratories Insider Transactions
Christopher J. Calamari Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher J. Calamari. You might contact Christopher J. Calamari via mailing address: 100 Abbott Park Road, Abbott Park Il 60064.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
